Proving the Business Case for the Internet of Things

Ascensia and Glooko partner to monitor blood glucose data

Steve Rogerson
February 14, 2017
 
The integration of technology from Ascensia Diabetes Care and Glooko will allow people with diabetes and health care professionals to access and analyse accurate blood glucose data at home, on the move and during office visits through the digital platform of their choice.
 
The collaboration integrates Califonia-based Glooko's diabetes data management platform and Swiss firm Ascensia's Contour Next One and Plus One blood glucose monitoring systems.
 
"Glooko's diabetes data management platform has become widely used for both personal and clinical diabetes data analytics and decision support," said Michael Kloss, CEO of Ascensia Diabetes Care. "Glooko's broad distribution into health systems will enable us to easily and seamlessly deliver highly accurate data from our Contour Next One and Plus One blood glucose monitoring systems to clinicians right in their workflow. By linking our systems to Glooko's platform, we want to enable better understanding and analysis of diabetes data, and ultimately help improve the lives of people with diabetes."
 
The integration will allow blood glucose data to be accessed by Glooko's mobile app and clinic data upload products directly from the glucose meters via Bluetooth and through an automatic feed via the Contour Cloud. People with diabetes will be able to view their data both in Glooko's mobile and web apps, as well as in the Contour diabetes app from Ascensia.
 
Health care professionals will be able to access data seamlessly from these two Ascensia systems in a way that fits directly into their workflow via the Glooko clinic product.
 
"The usability and accuracy of the blood glucose monitoring systems from Ascensia Diabetes Care is impressive and we are excited to bring these rich data into the Glooko platform to help both people with diabetes and their health care professionals manage this condition," said Rick Altinger, Glooko CEO.
 
The Next One system recently received 510(k) clearance from the FDA and Ascensia Diabetes Care expects to make this system available in the USA early this year. The Contour diabetes app will be available for download from the Apple App Store and Google Play.
 
In a clinical study, 95 per cent of blood glucose results obtained with Next One were within 8.4mg/dL (0.5 mmol/L) or 8.4 per cent of the reference result for subject fingertip tests. In a similar clinical study, 95 per cent of blood glucose results for Plus One were within 8.5mg/dL (0.5mmol/L) or 8.5 per cent of the reference result for subject fingertip tests.
 
Glooko is a population health platform for diabetes management and enables people with diabetes to track and better manage their condition more easily using mobile, web and cloud technology. Its mobile health app enables individuals to synchronise their data from a majority of the world's most popular diabetes and exercise devices including blood glucose meters. Glooko's population health application enables care teams to support people with diabetes remotely and aims to improve patient satisfaction and outcomes at a lower cost.